PlainRecalls
FDA Drug Moderate Class II Terminated

Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09

Reported: December 28, 2022 Initiated: December 7, 2022 #D-0089-2023

Product Description

Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09

Reason for Recall

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Details

Units Affected
23,736
Distribution
Product was distributed by major distribution chains nationwide.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 23,736.
Why was this product recalled?
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2022. Severity: Moderate. Recall number: D-0089-2023.